Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors
Status:
Completed
Trial end date:
2000-12-01
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of paclitaxel plus topotecan in treating patients
who have solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from
dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.